These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30392891)

  • 61. Cutting edge: analysis of human V alpha 24+CD8+ NK T cells activated by alpha-galactosylceramide-pulsed monocyte-derived dendritic cells.
    Takahashi T; Chiba S; Nieda M; Azuma T; Ishihara S; Shibata Y; Juji T; Hirai H
    J Immunol; 2002 Apr; 168(7):3140-4. PubMed ID: 11907064
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Alterations in cellular metabolism modulate CD1d-mediated NKT-cell responses.
    Webb TJ; Carey GB; East JE; Sun W; Bollino DR; Kimball AS; Brutkiewicz RR
    Pathog Dis; 2016 Aug; 74(6):. PubMed ID: 27297969
    [TBL] [Abstract][Full Text] [Related]  

  • 63. In vivo priming of natural killer T cells by dendritic cells pulsed with hepatoma-derived acid-eluted substances.
    Ishii R; Shimizu M; Nakagawa Y; Shimizu K; Tanaka S; Takahashi H
    Cancer Immunol Immunother; 2004 May; 53(5):383-90. PubMed ID: 14624311
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Immune response of HBsAg gene-modified dendritic cell-based vaccine in HepG2. 2. 15 hepatocellular carcinoma cells].
    Yang JY; Liu WC; Cao DY; Si XM; Teng ZH
    Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):728-32. PubMed ID: 18396682
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four alpha-fetoprotein peptides.
    Butterfield LH; Ribas A; Dissette VB; Lee Y; Yang JQ; De la Rocha P; Duran SD; Hernandez J; Seja E; Potter DM; McBride WH; Finn R; Glaspy JA; Economou JS
    Clin Cancer Res; 2006 May; 12(9):2817-25. PubMed ID: 16675576
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Potent expansion of human natural killer T cells using alpha-galactosylceramide (KRN7000)-loaded monocyte-derived dendritic cells, cultured in the presence of IL-7 and IL-15.
    van der Vliet HJ ; Nishi N; Koezuka Y; von Blomberg BM ; van den Eertwegh AJ ; Porcelli SA; Pinedo HM; Scheper RJ; Giaccone G
    J Immunol Methods; 2001 Jan; 247(1-2):61-72. PubMed ID: 11150537
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Alpha fetoprotein is more than a hepatocellular cancer biomarker: from spontaneous immune response in cancer patients to the development of an AFP-based cancer vaccine.
    Bei R; Mizejewski GJ
    Curr Mol Med; 2011 Oct; 11(7):564-81. PubMed ID: 21707514
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cutting edge: nonglycosidic CD1d lipid ligands activate human and murine invariant NKT cells.
    Silk JD; Salio M; Reddy BG; Shepherd D; Gileadi U; Brown J; Masri SH; Polzella P; Ritter G; Besra GS; Jones EY; Schmidt RR; Cerundolo V
    J Immunol; 2008 May; 180(10):6452-6. PubMed ID: 18453560
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Peroxisome proliferator-activated receptor γ-regulated cathepsin D is required for lipid antigen presentation by dendritic cells.
    Nakken B; Varga T; Szatmari I; Szeles L; Gyongyosi A; Illarionov PA; Dezso B; Gogolak P; Rajnavolgyi E; Nagy L
    J Immunol; 2011 Jul; 187(1):240-7. PubMed ID: 21632707
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Lack of ex vivo peripheral and intrahepatic α-fetoprotein-specific CD4+ responses in hepatocellular carcinoma.
    Witkowski M; Spangenberg HC; Neumann-Haefelin C; Büttner N; Breous E; Kersting N; Drognitz O; Hopt UT; Blum HE; Semmo N; Thimme R
    Int J Cancer; 2011 Nov; 129(9):2171-82. PubMed ID: 21170957
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Application of natural killer T cells in antitumor immunotherapy.
    Hong C; Park SH
    Crit Rev Immunol; 2007; 27(6):511-25. PubMed ID: 18197797
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mediastinal lymph node CD8alpha- DC initiate antigen presentation following intranasal coadministration of alpha-GalCer.
    Ko SY; Lee KA; Youn HJ; Kim YJ; Ko HJ; Heo TH; Kweon MN; Kang CY
    Eur J Immunol; 2007 Aug; 37(8):2127-37. PubMed ID: 17615581
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Apolipoprotein-mediated lipid antigen presentation in B cells provides a pathway for innate help by NKT cells.
    Allan LL; Hoefl K; Zheng DJ; Chung BK; Kozak FK; Tan R; van den Elzen P
    Blood; 2009 Sep; 114(12):2411-6. PubMed ID: 19620401
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Sulfatide inhibits α-galactosylceramide presentation by dendritic cells.
    Kanamori M; Tasumi Y; Iyoda T; Ushida M; Inaba K
    Int Immunol; 2012 Feb; 24(2):129-36. PubMed ID: 22247226
    [TBL] [Abstract][Full Text] [Related]  

  • 75. CD1 expression and CD1-restricted T cell activity in normal and tumour-bearing human liver.
    Kenna T; O'Brien M; Hogan AE; Exley MA; Porcelli SA; Hegarty JE; O'Farrelly C; Doherty DG
    Cancer Immunol Immunother; 2007 Apr; 56(4):563-72. PubMed ID: 16924493
    [TBL] [Abstract][Full Text] [Related]  

  • 76. NKT cells direct monocytes into a DC differentiation pathway.
    Hegde S; Chen X; Keaton JM; Reddington F; Besra GS; Gumperz JE
    J Leukoc Biol; 2007 May; 81(5):1224-35. PubMed ID: 17311932
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Herpes Simplex Virus 1 Specifically Targets Human CD1d Antigen Presentation To Enhance Its Pathogenicity.
    Rao P; Wen X; Lo JH; Kim S; Li X; Chen S; Feng X; Akbari O; Yuan W
    J Virol; 2018 Nov; 92(22):. PubMed ID: 30185591
    [TBL] [Abstract][Full Text] [Related]  

  • 78. CD1-restricted adaptive immune responses to Mycobacteria in human group 1 CD1 transgenic mice.
    Felio K; Nguyen H; Dascher CC; Choi HJ; Li S; Zimmer MI; Colmone A; Moody DB; Brenner MB; Wang CR
    J Exp Med; 2009 Oct; 206(11):2497-509. PubMed ID: 19808251
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Killing activity of human umbilical cord blood-derived TCRValpha24(+) NKT cells against normal and malignant hematological cells in vitro: a comparative study with NK cells or OKT3 activated T lymphocytes or with adult peripheral blood NKT cells.
    Hagihara M; Gansuvd B; Ueda Y; Tsuchiya T; Masui A; Tazume K; Inoue H; Kato S; Hotta T
    Cancer Immunol Immunother; 2002 Mar; 51(1):1-8. PubMed ID: 11845254
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Mycobacteria exploit p38 signaling to affect CD1 expression and lipid antigen presentation by human dendritic cells.
    Gagliardi MC; Teloni R; Giannoni F; Mariotti S; Remoli ME; Sargentini V; Videtta M; Pardini M; De Libero G; Coccia EM; Nisini R
    Infect Immun; 2009 Nov; 77(11):4947-52. PubMed ID: 19720761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.